Earth Science Tech Inc. (OTC: ETST) was featured in a recent article highlighting its unique position in the over-the-counter (OTC) markets due to its high insider ownership. The company's management team owns over 47% of the shares, a level that sets it apart from many other capitalization structures in the OTC landscape. According to the publication, this high level of insider ownership demonstrates that the leadership team strongly believes in the company and has their financial outcomes closely tied to the stock's performance.
This alignment significantly reduces the risk that management benefits while outside investors do not, as management is financially aligned with shareholders. The article notes that such high insider ownership ensures the company is intensely focused on creating shareholder value, since even a small swing in the stock price could have substantial financial implications for the team. It also indicates that the company funds operations through cash flow rather than toxic financing, which is a positive sign for investors.
Earth Science Tech operates as a strategic holding company focused on value creation through acquisition, operational optimization, and management of its operating businesses. Its current operations include compounding pharmaceuticals, telemedicine, and real estate development through wholly owned subsidiaries such as RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef.
For more details, the full article can be viewed at https://ibn.fm/i87X8. The latest news and updates about ETST are available in the company's newsroom at https://ibn.fm/ETST.
